Newsfeeds - Spark Newswire

1 minute read

BioCardia Q3 EPS $(0.16) Beats $(0.21) Estimate, Sales $821.00K Beat $10.00K Estimate

Today, 2:11 PM

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.21) by 23.81 percent. This is a 46.67 percent increase over losses of $(0.30) per share from the

BCDA

6 minute read

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance

By Shanthi Rexaline

Today, 2:11 PM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ACIU

18 minute read

Earnings Scheduled For November 10, 2021

By Benzinga Insights

Today, 2:11 PM

Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.

AACG

2 minute read

Legal
News

BioCardia Reports New US Patent For Technology To Enhance Control For Interventional Catheter Based Therapies

By Benzinga Newsdesk

Today, 2:11 PM

BioCardia®, Inc. (NASDAQ:BCDA) a company focused on developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the issuance of U.S. Patent

BCDA

2 minute read

BioCardia Announces First Cross-Over Patient Treated In CardiAMP Cell Therapy Heart Failure Trial

By Benzinga Newsdesk

Today, 2:11 PM

BioCardia®, Inc. (NASDAQ:BCDA) a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the treatment of the first

BCDA

4 minute read

50 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:11 PM

Gainers

ACY

3 minute read

32 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 2:11 PM

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share agreement with Google LLC to develop its enterprise tech platform and software products.

ADBE

1 minute read

News

Roumell Asset Management Reports In 13D Filing A 5.6% Stake In BioCardia

By Benzinga Newsdesk

Today, 2:11 PM

-SEC Filing

BCDA

1 minute read

BioCardia Q2 EPS $(0.20) Up From $(0.46) YoY

By Bill Haddad

Today, 2:11 PM

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.20) per share. This is a 56.52 percent increase over losses of $(0.46) per share from the same period last year.

BCDA

1 minute read

BioCardia Announces Japanese Patent On Imaging System For Targeting Cardiac Therapies

By Bill Haddad

Today, 2:11 PM

BioCardia®, Inc. (NASDAQ:BCDA), a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the Japan Patent Office has granted

BCDA